Citation Impact
Citing Papers
Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane
2016
Oxidative Stress
2017 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Cytosine methylation regulates oviposition in the pathogenic blood fluke Schistosoma mansoni
2011 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
KEAP1 and done? Targeting the NRF2 pathway with sulforaphane
2017
Environmental pollutants and the immune response
2020
Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review
2013
Suppression of microtubule dynamic instability and turnover in MCF7 breast cancer cells by sulforaphane
2008
Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention
2015
CpG islands and the regulation of transcription
2011 Standout
The history of cancer epigenetics
2004 Standout
Epigenetics: A Landscape Takes Shape
2007 Standout
Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells
2013
Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer
2012 StandoutNobel
Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles
2011
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome
2007 StandoutNobel
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
2003
Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells
2002
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Cancer chemoprevention: A radical perspective
2008
Marine natural products
1990 Standout
Epigenetic therapy of cancer: past, present and future
2006
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
SWI/SNF nucleosome remodellers and cancer
2011 Standout
Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder
2020
Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis (cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action
2015
DNA Methyltransferase Inhibitors and the Development of Epigenetic Cancer Therapies
2005
The Epigenomics of Cancer
2007 Standout
The Triterpenoid CDDO-Imidazolide Confers Potent Protection against Hyperoxic Acute Lung Injury in Mice
2009
Epigenetics in Cancer
2008 Standout
Cancer genes and the pathways they control
2004 Standout
Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China
2011
Targeting multidrug resistance in cancer
2006 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The Mammalian Epigenome
2007 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway
2008
DNA Methylation and Its Basic Function
2012 Standout
Gene Silencing in Cancer in Association with Promoter Hypermethylation
2003 Standout
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
How were new medicines discovered?
2011 Standout
Resistance to oxidants associated with elevated catalase activity in HL-60 leukemia cells that overexpress multidrug-resistance protein does not contribute to the resistance to daunorubicin manifested by these cells
1995
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Oxidative Stress in Cancer
2020 Standout
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
The Polycomb group protein EZH2 directly controls DNA methylation
2005 StandoutNature
Role of Formulation Vehicles in Taxane Pharmacology
2001
Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy
2008
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 Standout
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
2006 Standout
A decade of exploring the cancer epigenome — biological and translational implications
2011 Standout
DNA methylation and autoimmune disease
2003
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
The fundamental role of epigenetic events in cancer
2002 Standout
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Environmental epigenomics and disease susceptibility
2007 Standout
DNA methylation and human disease
2005 Standout
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
2003
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Role of 4-hydroxynonenal in chemopreventive activities of sulforaphane
2012
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
2021
TrxR1 as a Potent Regulator of the Nrf2-Keap1 Response System
2015
Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping.
2003 Nobel
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study
2001
Tumour stem cells and drug resistance
2005 Standout
Parallel Phase I Studies of Daunorubicin Given With Cytarabine and Etoposide With or Without the Multidrug Resistance Modulator PSC-833 in Previously Untreated Patients 60 Years of Age or Older With Acute Myeloid Leukemia: Results of Cancer and Leukemia Group B Study 9420
1999
Broccoli or Sulforaphane: Is It the Source or Dose That Matters?
2019
Histone deacetylases (HDACs): characterization of the classical HDAC family
2003 Standout
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine
2005
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1–Nrf2 Protein–Protein Interaction
2015
Epigenetic Reactivation of Tumor Suppressor Genes by a Novel Small-Molecule Inhibitor of Human DNA Methyltransferases
2005
ABERRANT DNA METHYLATION AS A CANCER-INDUCING MECHANISM
2005
Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo.
1998
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Design and Syntheses of Permethyl Ningalin B Analogues: Potent Multidrug Resistance (MDR) Reversal Agents of Cancer Cells
2010
A multidrug resistance transporter from human MCF-7 breast cancer cells
1998 Standout
Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal
2014 Standout
Epigenetic regulation of redox state mediates persistent cardiorespiratory abnormalities after long‐term intermittent hypoxia
2016 StandoutNobel
The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen.
1997
Stabilized sulforaphane for clinical use: Phytochemical delivery efficiency
2016
Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia
2003
Works of Brian Cornblatt being referenced
Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
2001
Identification of urinary metabolites that correlate with clinical improvements in children with autism treated with sulforaphane from broccoli
2018
Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance
1995
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
2007
Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL
1994
Bioavailability of Sulforaphane Following Ingestion of Glucoraphanin-Rich Broccoli Sprout and Seed Extracts with Active Myrosinase: A Pilot Study of the Effects of Proton Pump Inhibitor Administration
2019